MENU
SPRY
AS OF
Nov 13, 11:41 AM (EDT)
Price
$8.71
Change
-$0.23 (-2.57%)
Capitalization
884.2M
126 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
SPRY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

ARS Pharmaceuticals (SPRY) Earnings Date & Reports

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis... Show more

A.I. Advisor
published Earnings

SPRY is expected to report earnings to fall 30.52% to -36 cents per share on March 19

ARS Pharmaceuticals SPRY Stock Earnings Reports
Q4'25
Est.
$-0.36
Q3'25
Missed
by $0.06
Q2'25
Est.
$-0.46
Q1'25
Missed
by $0.01
Q4'24
Beat
by $0.61
The last earnings report on November 10 showed earnings per share of -51 cents, missing the estimate of -46 cents. With 256.82K shares outstanding, the current market capitalization sits at 884.20M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
SPRY
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SPRY showed earnings on November 10, 2025. You can read more about the earnings report here.
View AI-Driven Trading for SPRY
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
11682 El Camino Real
Phone
+1 858 771-9307
Employees
26
Web
https://www.ars-pharma.com